<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 50-year-old female patient, who had had a long-term history of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0005978'>type II diabetes mellitus</z:hpo>, had developed <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> and received allogeneic bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="1" pm="."><plain>She was being treated with tacrolimus, <z:chebi fb="0" ids="44185">methotrexate</z:chebi> and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> for prophylaxis and treatment of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, and with intensive insulin therapy for better glycemic control </plain></SENT>
<SENT sid="2" pm="."><plain>The patient suddenly developed marked <z:hpo ids='HP_0010741'>leg edema</z:hpo> at 27 days after starting intensive insulin therapy (on day 40 after BMT) without coexistence or exacerbation of apparent causes such as <z:hpo ids='HP_0000083'>renal failure</z:hpo>, cardiac dysfunction or leg <z:mp ids='MP_0005048'>thrombosis</z:mp> around the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0010741'>leg edema</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Interestingly, the <z:hpo ids='HP_0010741'>leg edema</z:hpo> regressed soon after daytime <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and intensive insulin therapy were performed </plain></SENT>
<SENT sid="4" pm="."><plain>Histopathological examination revealed slight dermal <z:hpo ids='HP_0000969'>edema</z:hpo> and small bullae with little inflammatory infiltration but no signs of autoimmune <z:mp ids='MP_0001208'>blistering</z:mp> diseases or <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>These findings indicate that the present case may be considered a form of so-called insulin <z:hpo ids='HP_0000969'>edema</z:hpo> occurring during intensive insulin therapy after BMT </plain></SENT>
</text></document>